Skip to main content

Cisatracurium Besylate Injection Shortage

Last Updated: August 11, 2022
Status: Current

Products Affected - Description
    • Cisatracurium besylate injection, AuroMedics, 2 mg/mL, 10 mL vial, 10 count, NDC 55150-0286-10
Reason for the Shortage
    • AuroMedics has cisatracurium on shortage due to increased demand.
    • Fresenius Kabi has cisatracurium injection available
    • Meitheal Pharmaceuticals has cisatracurium available.
    • Pfizer has cisatracurium injection available
    • Sandoz has cisatracurium injection available
    • Somerset has cisatracurium injection available.
    • Teva has cisatracurium injection available
    • AbbVie has Nimbex available.
Available Products
    • Nimbex injection, AbbVie, 10 mg/mL, 20 mL vial, 10 count, NDC 00074-4382-20
    • Nimbex injection, AbbVie, 2 mg/mL, 10 mL vial, 10 count, NDC 00074-4380-10
    • Nimbex injection, AbbVie, 2 mg/mL, 5 mL vial, 10 count, NDC 00074-4378-05
    • Cisatracurium besylate injection, AuroMedics, 2 mg/mL, 5 mL vial, 10 count, NDC 55150-0284-10
    • Cisatracurium besylate injection, Fresenius Kabi, 10 mg/mL, 20 mL vial, 10 count, NDC 63323-0418-20
    • Cisatracurium besylate injection, Fresenius Kabi, 2 mg/mL, 10 mL vial, 10 count, NDC 63323-0417-10
    • Cisatracurium besylate injection, Fresenius Kabi, 2 mg/mL, 5 mL vial, 10 count, NDC 63323-0416-05
    • Cisatracurium besylate injection, Meitheal Pharmaceuticals, 10 mg/mL, 20 mL vial, 10 count, NDC 71288-0713-21
    • Cisatracurium besylate injection, Meitheal Pharmaceuticals, 2 mg/mL, 10 mL vial, 10 count, NDC 71288-0714-11
    • Cisatracurium besylate injection, Meitheal Pharmaceuticals, 2 mg/mL, 5 mL vial, 10 count, NDC 71288-0712-06
    • Cisatracurium besylate injection, Pfizer, 10 mg/mL, 20 mL vial, 10 count, NDC 00409-1103-01
    • Cisatracurium besylate injection, Pfizer, 2 mg/mL, 10 mL vial, 10 count, NDC 00409-1208-01
    • Cisatracurium besylate injection, Pfizer, 2 mg/mL, 5 mL vial, 10 count, NDC 00409-1098-02
    • Cisatracurium besylate injection, Sandoz, 10 mg/mL, 20 mL vial, 10 count, NDC 00781-3153-95
    • Cisatracurium besylate injection, Sandoz, 2 mg/mL, 10 mL vial, 10 count, NDC 00781-3152-95
    • Cisatracurium besylate injection, Sandoz, 2 mg/mL, 5 mL vial, 10 count, NDC 00781-3150-95
    • Cisatracurium besylate injection, Somerset Therapeutics LLC, 10 mg/mL, 20 mL vial, 10 count, NDC 70069-0151-10
    • Cisatracurium besylate injection, Somerset Therapeutics LLC, 2 mg/mL, 10 mL vial, 10 count, NDC 70069-0161-10
    • Cisatracurium besylate injection, Somerset Therapeutics LLC, 2 mg/mL, 5 mL vial, 10 count, NDC 70069-0141-10
    • Cisatracurium besylate injection, Teva, 10 mg/mL, 20 mL vial, 10 count, NDC 00703-2056-03
    • Cisatracurium besylate injection, Teva, 2 mg/mL, 10 mL vial, 10 count, NDC 00703-2045-03
    • Cisatracurium besylate injection, Teva, 2 mg/mL, 5 mL vial, 10 count, NDC 00703-2033-03

Estimated Resupply Dates

    • Most marketed presentations are available.

Updated

Updated August 11, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 3, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer